Clinical Trial Update: Fluorouracil in Treating Patients With Recurrent or Metastatic Bladder Cancer [Phase 2]

View source ↗

Summary

Phase 2 study of fluorouracil in recurrent or metastatic bladder cancer, including transitional cell carcinoma of the renal pelvis and ureter and urethral cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Carcinoma of the Urethra
• Transitional Cell Carcinoma of the Renal Pelvis and Ureter

Drugs mentioned

• FLUOROURACIL (Fluorouracil)

Snippet

Sponsor: Medical Research Council | Conditions: Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter | Phase 2 | Status: COMPLETED